Clinical Trial Update: Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating discontinuation of beta-blockers in patients with heart failure and recovered left ventricular ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Heart Failure | Phase 3 | Status: RECRUITING